Comprehensive Analysis of ALG3 in Pan-Cancer and Validation of ALG3 as an Onco-Immunological Biomarker in Breast Cancer

Researchers focused on breast cancer to examine the influence of ALG3-mediated signaling pathways and intercellular interactions in the advancement of tumors. The biological effects of ALG3 were verified by breast cancer cells. Enhanced ALG3 expression was discovered to be substantially linked to patients’ grim prognoses in a number of malignancies.